2004
DOI: 10.1128/aac.48.6.2228-2232.2004
|View full text |Cite
|
Sign up to set email alerts
|

Penetration of Meropenem into Pneumonic Human Lung Tissue as Measured by In Vivo Microdialysis

Abstract: Until recently, information on antibiotic pharmacokinetic properties in infected human lung tissue was limited. We therefore studied a microdialysis-based approach for measurement of the penetration of meropenem into the extracellular space fluid of human pneumonic lung parenchyma. The lung penetration of meropenem was determined for seven patients with pneumonia and metapneumonic pleural empyema treated by decortication. Intraoperatively, two microdialysis probes were inserted into pneumonic lung tissue and o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(41 citation statements)
references
References 34 publications
0
40
1
Order By: Relevance
“…Haemodilution, hypothermia, redistribution of blood fl ow in the peripheral tissue, isolation of the lungs from the circulation, sequestration in the CPB equipment, decreased renal function, diminished protein binding, reduced clearance, changes in volume of distribution, the activation of the systemic infl ammatory reaction are factors that may alter the pharmacokinetic behaviour of antibiotics [16][17][18] . In the past various methods were developed to quantify the penetration of antibiotics into soft tissue, but major disadvantages of the these methods (skin blister fl uid method, biopsy and the tissue homogenisation, imaging procedures such as a positron emission tomography or magnetic resonance imaging) are limitations for tissue pharmacokinetic studies as well as inability to discriminate between free and bound fractions 19,20 . In the present study, we used in vivo microdialysis measurement of antibiotic tissue concentrations during the cardiac operation.…”
Section: Discussionmentioning
confidence: 99%
“…Haemodilution, hypothermia, redistribution of blood fl ow in the peripheral tissue, isolation of the lungs from the circulation, sequestration in the CPB equipment, decreased renal function, diminished protein binding, reduced clearance, changes in volume of distribution, the activation of the systemic infl ammatory reaction are factors that may alter the pharmacokinetic behaviour of antibiotics [16][17][18] . In the past various methods were developed to quantify the penetration of antibiotics into soft tissue, but major disadvantages of the these methods (skin blister fl uid method, biopsy and the tissue homogenisation, imaging procedures such as a positron emission tomography or magnetic resonance imaging) are limitations for tissue pharmacokinetic studies as well as inability to discriminate between free and bound fractions 19,20 . In the present study, we used in vivo microdialysis measurement of antibiotic tissue concentrations during the cardiac operation.…”
Section: Discussionmentioning
confidence: 99%
“…Improvements in the methodology used to sample ELF drug concentrations have addressed known limitations of the technique (144), namely, the inaccuracies associated with quantifying the ELF volume and the inability to sample the same site multiple times (145). Microdialysis has also been applied as a means to quantify lung concentrations of antimicrobials in human subjects (83,85,94,142,146,147). However, a limitation of the technique in this setting is that pulmonary infections may be located in different compartments (e.g., alveoli, bronchioles, and intracellularly) (148).…”
Section: In Vivo Studiesmentioning
confidence: 99%
“…8 To avoid the risk of pneumothorax, the performance of thoracotomy is inevitable ( Figure 2 ); thereby limiting MD experiments in the human lung to elective thoracic surgery. [9][10][11] However, if the MD probe is properly implanted under direct vision during conventionally performed lung surgery, no adverse events or clinical complications related to MD have been reported. [9][10][11] Lung MD in clinical studies was performed in spontaneously breathing patients after the end of the surgical procedures.…”
Section: Technical Challenges Of Lung MDmentioning
confidence: 99%
“…[9][10][11] However, if the MD probe is properly implanted under direct vision during conventionally performed lung surgery, no adverse events or clinical complications related to MD have been reported. [9][10][11] Lung MD in clinical studies was performed in spontaneously breathing patients after the end of the surgical procedures. In these studies fl exible custom-made MD probes (Metalant AB, Stockholm, Sweden) with a total length of ~50 cm to allow for pulmonal movement due to respiration were employed.…”
Section: Technical Challenges Of Lung MDmentioning
confidence: 99%